Mesirow Financial Investment Management, Inc. Adma Biologics, Inc. Transaction History

Mesirow Financial Investment Management, Inc.

  • $4.3 Billion
  • Q2 2024

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 16, 2024
BUY
$5.98 - $11.18 $362,100 - $676,971
60,552 New
60,552 $677 Million
Q1 2024

Apr 19, 2024
SELL
$4.4 - $6.74 $80,014 - $122,566
-18,185 Reduced 23.13%
60,420 $399 Million
Q4 2023

Jan 10, 2024
BUY
$3.08 - $4.52 $18,258 - $26,794
5,928 Added 8.16%
78,605 $355,000
Q3 2023

Nov 03, 2023
BUY
$3.47 - $4.61 $72,838 - $96,768
20,991 Added 40.61%
72,677 $260,000
Q2 2023

Jul 14, 2023
BUY
$3.12 - $4.22 $161,260 - $218,114
51,686 New
51,686 $190,000

Others Institutions Holding ADMA

# of Institutions
264
Shares Held
178M
Call Options Held
535K
Put Options Held
21.2K
View Full List

About ADMA BIOLOGICS, INC.

ADMA Quotes by TradingView
  • Ticker ADMA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 196,356,992
  • Market Cap $3.19B
  • Description
  • ADMA Biologics, Inc., a biopharmaceutical company, engages in developing, manufacturing, and marketing specialty plasma-derived biologics for the treatment of immune deficiencies and infectious diseases in the United States and internationally. It offers BIVIGAM, an intravenous immune globulin (IVIG) product indicated for the treatment of primar...
More about ADMA
Track This Portfolio

Track Mesirow Financial Investment Management, Inc. Portfolio

Follow Mesirow Financial Investment Management, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mesirow Financial Investment Management, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Mesirow Financial Investment Management, Inc. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email